Belite Bio Inc

Belite Bio Inc

World Rank (Jan-05-2024)

7,954

Market Cap (Jan-05-2024)

1.137 Billion USD

World Rank (Jul-30-2023)

11,043

Market Cap (Jul-30-2023)

0.656 Billion USD

Headquarters Country

Nasdaq / NYSE Code

BLTE

Market Cap (Mar-08-2026)

6.50

Headquarters City/State

World Region

World Subregion

Northern America

Business Sector

Biopharmaceutical

Company Website

Company Profile

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on aging metabolic diseases including dry age related macular degeneration, liver disease and diabetes. The headquarters is in United States.

IPO Year

2022

Stock Exchange

Nasdaq Sector

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations

Share